NEW YORK (GenomeWeb) – LGC said today that it has acquired BioAutomation, which manufactures the MerMade line of oligonucleotide synthesis instruments.
Terms of the deal were not disclosed.
BioAutomatic was founded in 1999 and employs 17 people at its facility in Irving, Texas. Its MerMade products include eight instruments that can synthesize four to 192 oligos simultaneously at scale ranges from 50 nmol to 200 umol, according to LGC. It also distributes consumables used during the synthesis process.